ACD PHARMACEUTICALS AS: årsregnskap 2012 vs 2011
Shrank 62% on revenue
approved 2013-06-10; registry 2013-07-18; journal 2013 574188
Summary
What changed
Comparing Årsregnskap 2012 with 2011 for ACD PHARMACEUTICALS AS. Revenue 20.22m NOK → 7.75m NOK (-61.7%). Equity 3.44m NOK → 5.05m NOK.
On the constructive side: equity strengthened; cash rose. Pressures included: revenue fell; payroll up without matching revenue.
Also worth watching: cogs fell; book investments changed. All figures are taken from the published annual accounts for ACD PHARMACEUTICALS AS.
At a glance
Scorecard
What improved
-
↑
Equity strengthened
Book equity 3.44m NOK → 5.05m NOK (equity ratio 29.6% → 50.6%). Calculated
-
↑
Cash rose
Bank deposits 67.0k NOK → 154.0k NOK (+130.0% YoY). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 20.22m NOK to 7.75m NOK (-61.7% YoY). Calculated
-
↓
Payroll up without matching revenue
Salary cost 558.6k NOK → 3.92m NOK (3% → 51% of revenue). Calculated
Things to notice
-
·
COGS fell
COGS / varekostnad 12.28m NOK → 1.17m NOK (-90.5% YoY). Calculated
-
·
Book investments changed
Investment / intangible book value 4 846 NOK → 10.0k NOK. Reported fact